.

The US Secretary of Health and Human Services, Kathleen Sebelius, has just signed a decree granting vaccine makers total legal immunity from any lawsuits that result from any new “Swine Flu” vaccine. Moreover, the $7 billion US Government fast-track program to rush vaccines onto the market in time for the Autumn flu season is being done without even normal safety testing. Is there another agenda at work in the official WHO hysteria campaign to declare so-called H1N1 virus—which has yet to be rigorously scientifically isolated, characterized and photographed with an electron microscope—the scientifically accepted procedure—a global “pandemic” threat?
The current official panic campaign over alleged Swine Flu danger is rapidly taking on the dimensions of a George Orwell science fiction novel. The document signed by Sebelius grants immunity to those making a swine flu vaccine, under the provisions of a 2006 law for public health emergencies.

Not so sage SAGE

That is once the WHO in Geneva, on recommendation of the WHO’s Strategic Advisory Group on Immunizations, declared H1N1 to be Phase 6 or Pandemic, automatic emergency health response programs could be activated even in countries such as Germany where reported outbreaks of even “suspected” H1N1 can be counted to date on the fingers of slightly more than one hand.

The WHO’s SAGE is also worth scrutiny. Its Chairman since 2005 has been the UK Director of Immunization at the British Department of Health, Dr David Salisbury. In the 1980’s Salisbury reportedly drew major fire for backing a massive vaccination of children with a multiple MMR vaccine manufactured by the predecessor company of GlaxoSmithKline. That vaccine was pulled off the market in Japan after significant numbers of children developed adverse reactions to the vaccine and the Japanese government was forced to pay significant compensation to the victims. In Sweden the MMR vaccine of GlaxoSmithKline was removed after scientists linked it to outbreaks of Crohn’s disease. Apparently that had little impact on WHO SAGE chairman Salisbury.

According to one independent UK investigator, Alan Golding, who obtained Freedom of Information documents on the case, in “1986 Trivirix, an MMR compound containing the Mumps Urabe strain AM-9, was introduced in Canada to replace MMR I. Concerns regarding the introduction of MMR in the UK are recorded in the minutes of the Joint Working Party of the British Paediatric Association and the Joint Committee on Vaccination and Immunization (JCVI) Liaison Group on June 26th of that year. Such concerns were soon to prove well grounded, as reports began to come in of an increased incidence of aseptic meningitis in vaccinated individuals. Ultimately, all MMR vaccines containing the Urabe strain of mumps were withdrawn in Canada in early 1988. This was before Urabe containing vaccines were licenced by the Department of Health for use in the UK…”

The report adds, “Smith-Kline—French, the pharmaceutical company who became Smith-Kline-Beecham and were involved in UK manufacture at that time, were concerned about these safety issues and were reluctant to obtain a UK license for their Urabe-containing vaccines. As a result of their ‘concern’ that children might be seriously damaged by one of their products, they requested that the UK government indemnify them against possible legal action that might be taken as a result of ‘losses’ associated with the vaccine, which by then was known to carry significant risk to health. The UK government, advised by Professor Salisbury and representatives from the Department of Health, in it’s enthusiasm to get a cheap MMR onto the market, agreed to this request.”

Today the same Dr Salisbury is advocating global proliferation of untested H1N1 vaccines, also manufactured by the same firm, now called GlaxoSmithKline.

The last phoney Swine Flu Disaster

The last time the US Government faced a new swine flu virus was in 1976. Thousands filed claims contending they suffered side effects from the shots. This time, the government has taken steps to prevent any possible legal remedy should thousands of US citizens suffer severe complications as a result of being given untested vaccines.

In 1976 President Gerald Ford, facing a difficult re-election campaign, was advised by the head of the CDC, David Sencer, to launch a mass national vaccination. As today with H1N1 Swine Flu, Sencer also used the scare of the alleged 1918 flu pandemic. Notably, some scientific researchers maintain that the deaths during the flu wave of 1918-1919, in the aftermath of the ghastly First World War, came not from any virus but from the governmental campaigns of mass vaccination against “Spanish Flu.” Interestingly, the Rockefeller University and Foundation was in the middle of that event as well.

Cases of what was then called swine flu were found in soldiers at Fort Dix, N.J. in 1976, including one death. That death, whose true cause is in dispute as the soldier, sick with influenza was put on a forced march despite and fell dead, was used by Sencer to convince Ford to launch one of the most infamous public health fiascos in US history, forcing Sencer’s resignation as CDC head. Federal officials vaccinated 40 million Americans during a national campaign. A pandemic never materialized, but thousands who got the shots filed injury claims, as they contracted a paralyzing condition called Guillain-Barre Syndrome or other side effects. At least 25 people died after receiving the vaccine died and 500 developed Guillain-Barre syndrome, an inflammation of the nervous system which can cause paralysis and be fatal. The US Government was forced to pay damages after vaccination victims made it a national scandal. In the end the 1976 Swine Flu vaccine proved far worse than the disease.

Sencer was fired in 1977 for the fiasco but by then the damage had already been done.

No Safety Test? Don’t worry, be happy…

The story gets worse. Now that the Obama Administration has signed a document of immunity from legal prosecution, the FDA in the United States and UK health authorities have decided to let Big Pharma put vaccine products onto the market before any tests of the possible harmful side effects of the vaccines are even known.

The first doses of swine flu vaccine will be given to the public before full data on its safety and effectiveness become available. The untested “pandemic” vaccines will be spread over two doses in a higher quantity, and one brand reportedly will contain a chemical additive, an adjuvant, to make it “go further,” dramatically potentially increasing the risk of side-effects.

Children will be among those first in line for the shots and may get the vaccine more than a month before trial results are received.

In the UK the government’s National Health Service, NHS, has been ordered to plan for a worst-case scenario in which swine flu might cause 65,000 deaths over the coming winter, including several thousand deaths among children.

The British Government has placed advance orders for 132 million doses of vaccine with two manufacturers, GlaxoSmithKline and Baxter, who have licensed “in advance” three “core” vaccines in preparation for a pandemic, conveniently enough even though we are told by WHO and epidemiologists that we cannot prepare in advance for what could be a more ominous mutation of the currently very mild H1N1 problem.

Curiously enough, a full year before any reported case of the current alleged H1N1, the major pharmaceutical company, Baxter, filed for a patent for H1N1 vaccine: Baxter Vaccine Patent Application US 2009/0060950 A1. Their application states, “the composition or vaccine comprises more than one antigen…..such as influenza A and influenza B in particular selected from of one or more of the human H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, H10N7 subtypes, of the pig flu H1N1, H1N2, H3N1 and H3N2 subtypes, of the dog or horse flu H7N7, H3N8 subtypes or of the avian H5N1, H7N2, H1N7, H7N3, H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8, H10N7, H2N2, H8N4, H14N5, H6N5, H12N5 subtypes.”

The application further states, “Suitable adjuvants can be selected from mineral gels, aluminium hydroxide, surface active substances, lysolecithin, pluronic polyols, polyanions or oil emulsions such as water in oil or oil in water, or a combination thereof. Of course the selection of the adjuvant depends on the intended use. E.g. toxicity may depend on the destined subject organism and can vary from no toxicity to high toxicity.”

With no legal liability, could it be that Baxter is preparing to sell hundreds of millions of doses containing highly toxic aluminium hydroxide as adjuvant? Perhaps it is time to demand that all leading officials of WHO, SAGE and CDC, the US Obama Administration, Cabinet officials and members of Congress w, the US Obama Administration, Cabinet officials and members of Congress who voted the $7 billion H1N1 emergency funds and who have gone along with the declaration of pharmaceutical company immunity from subsequent prosecution for damage from their products. The same should apply as well for other national health bodies demanding its citizens take the H1N1 vaccine from GlaxoSmithKline or Baxter to see if it is really safe.

And WHO stopped even tracking H1N1

Another indication that the world is being taken for colossal suckers in the entire WHO Swine Flu scare scenario, the WHO itself, the world body entrusted to monitor outbreaks of so-called pandemics or even epidemics worldwide, has just decided to stop tracking Swine Flu or H1N1 Influenza A as they prefer to name it now, so as not to offend Smithfield Foods and other industrialized pig CAFO producers.

The World Health Organization in a “briefing note” posted on their Web site posted the baffling notice that they would no longer track outbreaks of H1N1. The last WHO update, issued July 6, showed 94,512 confirmed cases in 122 countries, with 429 deaths. The WHO apparently claims that the numbers of laboratory-confirmed cases were actually meaningless.

The briefing note said countries would still be asked to report their first few confirmed cases. It also said countries should watch for clusters of fatalities, which could indicate the virus had mutated to a more lethal form. Other “signals to be vigilant for,” it said, were spikes in school absenteeism and surges in hospital visits. The Atlanta CDC has also agreed to the WHO count drop. Dr. Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, admits that the existing tests to confirm H1N1 Influenza A are not even certain, but rather hit-or-miss. “Bad measures can be worse than no measures at all,” he stated. So the WHO has decided to drop tests that anyway did not give a scientific picture of who had H1N1 or not, and as well they have decided to drop counting any test results or cases of H1n1 around the world with the comment that “we can assume almost all cases are H1N1 Swine Flu. This is science on which basis we are told to vaccinate our young? Whoah there…Not with our children.

F. William Engdahl
Global Research

Around 12,000 U.S. children will be used as guinea pigs for an experimental swine flu vaccine known to contain the dangerous ingredient squalene, which has been directly linked with cases of Gulf War Syndrome and a host of other debilitating diseases.

According to a report in the Oklahoman, 12,000 children nationwide will partake in “fast-tracked studies” to test the side-effects of the untested swine flu vaccine in trials set to begin next month.

“The trials will test the vaccine’s effectiveness and whether or not it has negative side effects in patients,” states the report.

Since less than 100 children in the U.S. die from regular seasonal flu each year, a reasonable estimate would be that around 100 children will die from swine flu over the course of the next year.

So in effect, the authorities will vaccinate millions of children in order to try and prevent 100 deaths. If the mass vaccination program mirrors the previous swine flu outbreak of 1976 then the vaccine is likely to kill more people than the actual virus.

Furthermore, since the swine flu vaccine includes squalene, a dangerous adjuvant that contributed to Gulf War Syndrome cases, there’s little doubt that it will lead to debilitating lifelong diseases far more deadly than the swine flu virus itself for thousands of children if a mass vaccination campaign is conducted.

According to Meryl Nass, M.D., “A novel feature of the two H1N1 vaccines being developed by companies Novartis and GlaxoSmithKline is the addition of squalene-containing adjuvants to boost immunogenicity and dramatically reduce the amount of viral antigen needed. This translates to much faster production of desired vaccine quantities.”

“Research shows that squalene is the experimental anthrax vaccine ingredient that caused devastating autoimmune diseases and deaths for many Gulf War veterans from the US, UK, and Australia, yet it continues in use today and for new vaccines development in labs,” writes Stephen Lendman.

According to award-winning investigative journalist Gary Matsumoto, there’s a “close match between the squalene-induced diseases in animals and those observed in humans injected with this oil: rheumatoid arthritis, multiple sclerosis and systemic lupus erythematosus.”

“There are now data in more than two dozen peer-reviewed scientific papers, from ten different laboratories in the US, Europe, Asia and Australia, documenting that squalene-based adjuvants can induce autoimmune diseases in animals…observed in mice, rats, guinea pigs and rabbits. Sweden’s Karolinska Institute has demonstrated that squalene alone can induce the animal version of rheumatoid arthritis. The Polish Academy of Sciences has shown that in animals, squalene alone can produce catastrophic injury to the nervous system and the brain. The University of Florida Medical School has shown that in animals, squalene alone can induce production of antibodies specifically associated with systemic lupus erythematosus,” writes Matsumoto.

Micropaleontologist Dr. Viera Scheibner, who conducted research into the adverse effects of adjuvants in vaccines, wrote the following about squalene.

Squalene “contributed to the cascade of reactions called “Gulf War syndrome. (GIs developed) arthritis, fibromyalgia, lymphadenopathy, rashes, photosensitive rashes, malar rashes, chronic fatigue, chronic headaches, abnormal body hair loss, non-healing skin lesions, aphthous ulcers, dizziness, weakness, memory loss, seizures, mood changes, neuropsychiatric problems, anti-thyroid effects, anaemia, elevated ESR (erythrocyte sedimentation rate), systemic lupus erythematosus, multiple sclerosis, ALS, Raynaud’s phenomenon, Sjorgren’s syndrome, chronic diarrhea, night sweats and low-grade fever.”

Paul Joseph Watson
Infowars
Read Entire Article

H1N1 swine flu attacks the respiratory system in a more sustained way than the standard seasonal virus, research in animals shows.

Tests showed swine flu multiplies in greater numbers across the respiratory system, and causes more damage.

And instead of staying in the head like seasonal flu, it penetrates deeper into the respiratory tissues - making it more likely to cause pneumonia.

The University of Wisconsin study appears in the journal Nature.

It also suggests that swine flu may mimic the flu virus which caused the great pandemic of 1918, in which millions died.

The 1918 virus also had a greater ability than standard flu to cause damage to the respiratory system.

The researchers carried out their work on ferrets, monkeys and mice.

They also analysed samples taken from people who survived the 1918 pandemic and found that they seem to have extra immune protection against the current virus - again suggesting similarities.

However, the Wisconsin team stressed that swine flu produced, in the vast majority of cases, only mild symptoms, and is still sensitive to anti-viral drugs.

Complete analysis

Professor Ian Jones, a flu expert at the University of Reading, said the latest study provided the complete analysis of the swine flu that researchers had been waiting for.

He said: "For a number of measures it shows that the new virus is more serious than seasonal H1N1 but that, nonetheless, the major outcome to infection is recovery.

"For the few cases of severe infection the data should help in the clinical management of hospitalised patients.

Professor Wendy Barclay, an expert in virology at Imperial College London, said: "It must be borne in mind that typical circulating human strains of H1N1 have been associated with rather mild illness in recent years, and that the swine origin H1N1 may be behaving in these animal models more alike the type of H3N2 viruses that caused a pandemic in 1968."

Swine flu is estimated to have infected more than a million people worldwide, and to have killed at least 500.

BBC

The federal government is committing more than $800 million to buy more of the two key ingredients to make the H1N1 swine flu vaccine, according to the Department of Health and Human Services.

The money will be used to place additional orders on existing contracts with vaccine manufacturers including GlaxoSmithKline and Novartis. The former Chiron Corp. facility in Emeryville is now owned by Novartis, which makes vaccines there.

The government is placing orders for antigen and adjuvant. Antigen is the active ingredient in a vaccine that triggers the immune system to develop antibodies to fight the H1N1 virus. Adjuvant is added to boost the immune system and reduce the amount of antigen needed for the vaccine. The vaccine ingredients will become a part of the pandemic stockpile, for use if a vaccination campaign is necessary.

All Britons could be vaccinated against the A/H1N1 flu as the number of confirmed cases in Britain is moving closer toward 10,000, health authorities said Sunday.
The first doses of A/H1N1 vaccine are set to arrive in Britain in September and could be fast-tracked through regulatory approval in less than a week.

Health officials have put forward plans to build a nationwide immunity to the disease, the biggest vaccination program of the past 50 years.

Health experts have already provided a priority list of patients, and the fast-tracking system has been established since the first British patient without underlying health problems died of the disease.

Lead negotiator on A/H1N1 of the British Medical Association Peter Holden told the Sunday Times the high risk groups will be done at the local clinics.

He added that if the virus does mutate, the idea is to give people immunity, but he also admitted that the sheer logistics of dealing with 60 million people can’t be underestimated.

It is reported on Friday that a patient at an Essex hospital has become the first person in Britain without underlying health problems to die of the infection, bringing the death toll in the country to 15.

It is expected to surge in the winter months when flu is more prevalent.

There are 9,718 confirmed cases of A/H1N1 in Britain, according to the latest figures from the Health Protection Agency.

Xinhua News Agency

On July 2, Obama’s Office of the Press Secretary posted a press release on the White House website. It announced “an all-day H1N1 Flu Preparedness Summit… to further prepare this nation for the possibility of a more severe outbreak of H1N1 flu.” The announced summit is to be held today at the Natcher Conference Center at the National Institutes of Health in Bethesda, Maryland. Health and Human Services Secretary Kathleen Sebelius, Homeland Security Secretary Janet Napolitano, Education Secretary Arne Duncan, and Homeland Security Advisor John Brennan are hosting the summit.

“Scientists and public health experts forecast that the impact of H1N1 may well worsen in the fall – when the regular flu season hits, or even earlier, when schools start to open – which is only five or six weeks away in some cases,” Sebelius is quoted in the press release. “The goal of the Summit is to launch a national influenza campaign by bringing federal, state and local officials, emergency managers, educators and others together with the nation’s public health experts to build on and tailor states’ existing pandemic plans, share lessons learned and best practices during the spring and summer H1N1 wave, and discuss preparedness priorities.”

Infowars
Read Entire Article

Vaccinations against swine flu are likely and probably will begin in mid-October, assuming soon-to-start studies go well.

The government will fully pay for any autumn vaccination program against the new H1N1 swine flu, Health and Human Services Secretary Kathleen Sebelius said on Thursday.

“We have already appropriated about a billion dollars to buy the bulk ingredients,” Sebelius told a swine flu “summit” of state and local leaders at the National Institutes of Health.

She said another $7.5 billion was available from emergency preparedness funds.

President Barack Obama telephoned the NIH all the way from Italy Thursday to tell a meeting of 500 flu officials not to promote panic — but to make sure “we are promoting vigilance and preparation.”
MSNBC
Read Entire Article